Found partially in the 38 X Found partially in the 38Configure X
E ffectI nfluenceCases ⓘ X
E ffect - how much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E ) is high, but the effect (I ) negative, because the patient will get worse over time.I nfluence of the symptom on the outcome of the patient's treatment as a whole (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
d43.7 neoplasm of uncertain or unknown behaviour, other parts of central nervous system 34% -14% 20 read Hydrastis canadensis Oncology - E 34% (I -14% , 20 cases.); Central nervous system - E 38% (I -1% , 10 cases.)
33% +7% 12 read Aurum metallicum 30% -7% 6 read Cundurango 30% +2% 71 read Silica terra Oncology - E 30% (I 2% , 71 cases.); Central nervous system - E 45% (I 5% , 78 cases.)
28% +7% 52 read Conium maculatum Oncology - E 28% (I 7% , 52 cases.); Central nervous system - E 56% (I 9% , 52 cases.)
27% -2% 15 read Apis mellifica Oncology - E 27% (I -2% , 15 cases.); Central nervous system - E 49% (I -6% , 15 cases.)
27% +0% 92 read Lycopodium clavatum Oncology - E 27% (I 0% , 92 cases.); Central nervous system - E 34% (I 4% , 148 cases.)
26% +2% 4 read Aurum muriaticum Oncology - E 26% (I 2% , 4 cases.); Central nervous system - E 52% (I 21% , 4 cases.)
23% +1% 8 read Phytolacca decandra Oncology - E 23% (I 1% , 8 cases.); Central nervous system - E 28% (I 0% , 9 cases.)
22% -18% 17 read Chelidonium majus Oncology - E 22% (I -18% , 17 cases.); Central nervous system - E 53% (I 3% , 20 cases.)
21% +0% 143 read Phosphorus Oncology - E 21% (I 0% , 143 cases.); Central nervous system - E 41% (I 2% , 208 cases.)
21% -17% 10 read Kali phosphoricum Oncology - E 21% (I -17% , 10 cases.); Central nervous system - E 32% (I -9% , 22 cases.)
20% -10% 6 read Glonoinum Oncology - E 20% (I -10% , 6 cases.); Central nervous system - E 45% (I 8% , 9 cases.)
19% +21% 10 read Plumbum metallicum Oncology - E 19% (I 21% , 10 cases.); Central nervous system - E 47% (I 8% , 16 cases.)
18% -13% 15 read Belladonna Oncology - E 18% (I -13% , 15 cases.); Central nervous system - E 42% (I 11% , 40 cases.)
17% -2% 26 read Bryonia alba Oncology - E 17% (I -2% , 26 cases.); Central nervous system - E 46% (I 5% , 59 cases.)
15% +1% 24 read Tuberculinum Oncology - E 15% (I 1% , 24 cases.); Central nervous system - E 25% (I -4% , 73 cases.)
15% -1% 108 read Pulsatilla nigricans Oncology - E 15% (I -1% , 108 cases.); Central nervous system - E 38% (I 6% , 199 cases.)
14% -8% 8 read Spigelia anthelmia Oncology - E 14% (I -8% , 8 cases.); Central nervous system - E 30% (I -3% , 24 cases.)
13% -2% 103 read Lachesis muta Oncology - E 13% (I -2% , 103 cases.); Central nervous system - E 36% (I 4% , 183 cases.)
11% -7% 43 read Causticum hahnemanni Oncology - E 11% (I -7% , 43 cases.); Central nervous system - E 34% (I 1% , 90 cases.)
11% -1% 70 read Calcarea carbonica Oncology - E 11% (I -1% , 70 cases.); Central nervous system - E 37% (I 4% , 127 cases.)
6% +7% 7 read Iodum purum Oncology - E 6% (I 7% , 7 cases.); Central nervous system - E 55% (I 29% , 6 cases.)
6% -34% 23 read Crotalus horridus Oncology - E 6% (I -34% , 23 cases.); Central nervous system - E 32% (I -6% , 36 cases.)
-1% -20% 5 read Carbo animalis -6% -27% 6 read Zincum metallicum Oncology - E -6% (I -27% , 6 cases.); Central nervous system - E 7% (I 1% , 14 cases.)
Alumen read Asterias rubens read Bufo rana read Citrus limonum read Echinacea angustifolia read Ficus religiosa read Galium aparine read Kali cyanatum read Muriaticum acidum read Sempervivum tectorum read Tarentula hispanica read Viburnum prunifolium read